Democrats gain Senate control, raising uncertainty for Trump-era health policies
Democrats have secured Senate control, giving them the ability to challenge Trump-era health care actions. This shift could affect regulatory priorities for healthcare and pharma leaders. Watch for policy changes that may alter compliance or market strategies.
FDA and CMS seek state partnerships on AI regulation and liability in healthcare
Federal officials plan to work with states on regulating AI and protecting doctors from AI liability, according to STAT. This move could reshape how AI tools are governed and used in healthcare. Senior leaders should watch for new compliance and risk frameworks.
White House AI task force omits CISA, raising security concerns
The White House’s new AI task force does not include the Cybersecurity and Infrastructure Security Agency. Experts say this could hinder efforts to address AI security for critical infrastructure. Senior leaders should assess how this may affect sector risk.
FDA approves generic HIV prevention shot for global access
The FDA has approved a generic HIV prevention shot, aiming to expand access in lower-income countries. This move could affect drug pricing and public health policy for pharma and healthcare leaders. Watch for changes in procurement and global health strategy.
AMA says AI vendors and health systems share liability for clinical AI
The AMA has set out that physicians, AI developers and healthcare organisations each hold responsibility for clinical AI. This widens the scope of liability in patient care. Healthcare leaders should review risk and compliance processes now.
Four drugmakers accused of paying millions to Russian middlemen for drug supply
STAT reports that four major drugmakers allegedly paid tens of millions to middlemen to supply lifesaving drugs to Russian government entities. This raises compliance and reputational risks for pharma leaders. Firms may need to review third-party controls and due diligence.
Meta puts legal risk for AI ad content on advertisers ahead of November change
Meta is updating its terms to make advertisers solely responsible for AI-driven ad content. Marketing leads in regulated sectors must review their creative processes and risk controls. Teams should audit AI ad enhancements before the November 20 deadline.
AI firms allow opt-out for web data, but most data already collected
Four major AI firms will now let websites opt out of data scraping, according to Inc. However, much of the internet has already been scraped. Regulated-industry leaders face ongoing risks around data governance and privacy compliance.
US Republicans join Democrats in targeting CVS over drug prices
Republicans have joined Democrats in criticising pharmacy groups like CVS for high drug prices, according to Politico. This signals growing bipartisan scrutiny of pharmacy benefit managers. Senior healthcare and pharma leaders should expect more regulatory attention.
CVS sues to avoid $2B loss from Medicare Advantage ratings drop
CVS has filed a lawsuit to prevent a $2 billion financial hit from lower Medicare Advantage star ratings, according to Healthcare Dive. The case signals growing legal pushback from insurers over rating changes. Senior healthcare leaders should monitor legal outcomes and regulatory responses.
US judge says federal agency overreached on Medicaid work rules
A federal judge found regulators went too far in limiting exceptions to Medicaid work requirements. This affects health insurers and providers managing compliance risk. Watch for further legal and policy shifts on Medicaid eligibility rules.
US Justice Department questions Nvidia’s $12.9B Hugging Face acquisition
The US Justice Department is examining Nvidia’s $12.9B deal for Hugging Face, focusing on competition in AI and concerns over control of a key model distribution platform. Senior leaders should assess how regulatory scrutiny could affect AI partnerships and access. Watch for potential delays or conditions.
Equifax settles $100m class action over credit score miscalculation
Equifax has agreed to pay $100 million to settle claims it miscalculated credit scores for 4 million Americans. For banks and insurers, the case shows the operational and reputational risks in data management. Watch for further scrutiny on credit bureaus’ processes.
US laws put new scrutiny on algorithmic pricing for marketers
New US state and federal laws are raising concerns about algorithmic pricing, according to Simpson Thacher & Bartlett LLP. Marketers in regulated sectors face fresh legal risks as rules evolve. Firms should monitor legal trends and review pricing strategies for compliance.
Galaxy Digital seeks OCC charter to expand digital asset services
Galaxy Digital is applying for a national trust charter, according to its CEO. This would let the firm offer digital asset custody and other services under one federal framework. Regulated firms should watch for OCC decisions that could shape digital asset access.
Vertex kidney drug faces scrutiny over infection risk before FDA decision
Vertex’s kidney disease drug is under heavy scrutiny for infection risk ahead of a key FDA approval decision on 30 November. Senior pharma leaders should note the regulatory focus on safety. The outcome may affect future drug approvals and market entry strategies.
Biopharma firms split over Treasury’s China rule exemption
A proposed Treasury rule has sparked debate in the biopharma sector over an exemption for certain deals with China. Senior pharma leaders face regulatory uncertainty affecting cross-border collaborations. Companies should assess deal structures and monitor rule changes.
US rule orders pharmacy benefit managers to reveal secret payments
A new US rule will require pharmacy benefit managers to disclose previously hidden fees and compensation. This change could affect pricing and transparency for health insurers and pharma companies. Firms should prepare for possible shifts in contract terms and regulatory scrutiny.
FTC and eight states sue Toast over alleged hidden fees in restaurant payments
The FTC and eight states have taken legal action against Toast, claiming it charged hidden fees to restaurant clients and customers. This raises compliance risks for payments providers and banks serving the sector. Watch for regulatory scrutiny of fee transparency.
Binance halts withdrawals after suspected multi-billion dollar crypto theft
Binance has suspended withdrawals after hackers reportedly drained up to $5.7 billion from its wallets, according to TechCrunch. This incident raises major security and operational risks for financial firms using crypto infrastructure. Firms should monitor for updates and review their own protocols.